Search - tctmd.com

Displaying 41 - 60 of 245

Sort: Relevancy | Date

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Clinical Characteristics and Predictors of Mortality in Cardiogenic Shock: A PREMIER Healthcare Database Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT 2025

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Presenter: Emily Rodriguez

February 11, 2025

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Presenter: Tahira Qadeer

February 11, 2025

Presentation THT 2025

Prospective Validation of Machine Learning in Risk Stratification of Patients Treated for Cardiogenic Shock

Presenter: Shuojohn Li

February 11, 2025

Presentation THT 2025

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Presenter: Allan Böhm

February 11, 2025

Presentation THT 2025

The Percutaneous Synchronized Cardiac Assist (PSCA) System for Extravascular Mechanical Circulatory Support: A Safety and Hemodynamic Performance Study

Presenter: Petr Neuzil

February 11, 2025

$Effect of eLym-based Lymphatic Drainage System on Persistent Pulmonary Edema in Patients With Cardiogenic Shock Refractory to Maximal Therapy: A Pilot Study$

Presentation THT 2025

Effect of eLym-based Lymphatic Drainage System on Persistent Pulmonary Edema in Patients With Cardiogenic Shock Refractory to Maximal Therapy: A Pilot Study

Presenter: Sumitabh Singh

February 11, 2025

Presentation THT 2025

Intensive Conditioning to Reduce Frailty in Cardiogenic Shock: The InCoR-FCS Study

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Presenter: Mahir Karakas

February 11, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Time to Escalation: From the Golden Day to the Golden Six Hours

Presenter: Elric Zweck

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Presenter: Matteo Pagnesi

February 11, 2025

Presentation THT 2025

Technologies Targeting Acute Limb Ischemia in Cardiogenic Shock

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Magenta Elevate™ pLVAD: Breaking the Flow/Fr Size Ceiling of Mechanical Circulatory Support

Presenter: Ajay Kirtane

February 11, 2025

Advertisement

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Clinical Characteristics and Predictors of Mortality in Cardiogenic Shock: A PREMIER Healthcare Database Analysis

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Prospective Validation of Machine Learning in Risk Stratification of Patients Treated for Cardiogenic Shock

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

The Percutaneous Synchronized Cardiac Assist (PSCA) System for Extravascular Mechanical Circulatory Support: A Safety and Hemodynamic Performance Study

Effect of eLym-based Lymphatic Drainage System on Persistent Pulmonary Edema in Patients With Cardiogenic Shock Refractory to Maximal Therapy: A Pilot Study

Intensive Conditioning to Reduce Frailty in Cardiogenic Shock: The InCoR-FCS Study

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Harnessing Real World Data to Test Emerging Technologies

Time to Escalation: From the Golden Day to the Golden Six Hours

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Optimizing Outcomes in Cardiac Arrest and Shock

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Technologies Targeting Acute Limb Ischemia in Cardiogenic Shock

Magenta Elevate™ pLVAD: Breaking the Flow/Fr Size Ceiling of Mechanical Circulatory Support

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content